|Day Low/High||108.22 / 110.10|
|52 Wk Low/High||104.17 / 132.13|
The weekly breakout is pretty impressive on the charts, so let's take a look.
The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.
This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.
Top pharmaceutical companies are paving the way to a cure for Alzheimer's, a degenerative disease that is affecting millions around the world.
Here are some options strategies for this FANG name into tomorrow's report.
Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.
You should be thinking positively these days if your stock has had a run or even if it hasn't as a preponderance of good things is liable to happen.
All three major averages closed Thursday's session in positive territory.
Forward looking valuations, except for Nvidia, are very low.
I think M&A activity will pick up markedly going forward across the industry.
For Women's History Month, Alpha Rising sat down with Nancy Lieberman, Of Counsel at Skadden, Arps. She was and still is the youngest person to ever make partner at her firm. She has worked on some of the biggest M&A deals in history -- and we should mention -- she's in a wheelchair and barely as use of her hands. Feel like a slacker yet? Good. Watch.
Traders should stay alert and nimble with LLY stock.
The price of LLY has climbed and the bearish price target on the Point and Figure chart is off the table.
Consider this LLY bullishly biased vertical call spread expiring in June.
We could be poised for even a further advance PROVIDED that we stay oversold.
Consider this LLY out of the money, bullishly biased vertical call spread expiring in April.
Facebook is making itself a tough own ahead of the quarterly results.
Who, out there in the health care sector, is safe?
Prices have improved the past eight weeks and now I want to turn up the volume.
* Thus far, my expectation of an "inside day" has been accurate. SPDR S&P 500 ETF has traded in a fifty cent range most of the day. * Bonds are at the day's highs. +$0.88. Yield on the 10-year U.S. note is down by 3.5 basis points to 2.32% (where y...
In terms of sector price movement today: * FANGs continue to extend recent gains. * Retail has picked up a bid late in the day. Walmart Dillard's and Foot Locker are upside features. * Big Pharma stronger -- led by Merck ,Bristol-Myers Squibb , Lil...